The @ATS_PC invites you to join their upcoming webinar: “Publishing in High Impact Journals: Insights from Experts” 📚✨Learn more and register now! bit.ly/4dT9Oqq
🗓 Thur, June. 18, 2026
⏰ 1:30 p.m. ET
We are thrilled to announce an opening for a tenure-track assistant professor in PCMM, Boston Children's Hospital and Harvard Immunology! Apply by August 2, 2026.
Look no further for your Monday inspiration - we are back with another Early Career Highlight! 🥁 Dr. Kim is a postdoctoral fellow at Harvard Medical School.
Registration is now open! 📢
Genetics-inspired Therapeutics for Pulmonary Hypertension
🗓️ 2 June 2026
🕐 09:00 - 18:30 GMT
📌 Royal College of Physicians, London
Join us for a one-day Symposium exploring how advances in genetics are shaping the future of PH therapies. We'll be bringing together global experts to examine what that means in practice – for biology, clinical trials, and future therapies.
➡️ Register now: pvrinstitute.org/learning-hu…
If you're a PVRI member, you’ll receive a 10% discount. Access it here: pvrinstitute.org/genetics-in…
Thank you all for organizing the workshop! As early career researcher, I found all the panelists, including my mentor @GoncharovaLab, shared valuable insights and answered important questions. To echo Elena’s comments, please consider join and volunteer in PC ECWG activities!
Presented at #ERSCongress:
Among adults with pulmonary arterial hypertension who had received the diagnosis less than 1 year earlier, the addition of sotatercept to background therapy resulted in a lower risk of clinical worsening than placebo. Full HYPERION phase 3 trial results: nej.md/4mzuaY1@EuroRespSoc
ALT A graph showing the primary efficacy end point (intention-to-treat population).
What an experience in submitting my first R01! Sincerely appreciate all the support from my collaborators, colleagues, lab members, my department and the university! My thanks also extend to my husband, my extend family and my pets❤️
Check out my first first-author publication in @AJPLung ! I’m so excited to share my dissertation research on the nitrofen/ bisdiamine model of CDH associated pulmonary hypertension.